$547.55
Price
$138.8B
Market Cap
31.9
P/E Ratio
24.9
Forward P/E
$17.18
EPS (TTM)
—
Dividend Yield
$7.9B
Cash
$2.0B
Total Debt
253M
Shares Out
$374.17
$555.69
52-Week Range
Institutional Ownership of Vertex Pharmaceuticals Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 40.1K | $20M | $355.48 | +54.03% |
Trading Activity for Vertex Pharmaceuticals Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | -0.7% | 40.1K | $20M | $438.40 | |
| 2026-Q1 | |||||
| BUY | +3.4% | 40.4K | $18M | $467.87 | |
| 2025-Q3 | |||||
| BUY | +4.9% | 39.1K | $15M | $395.92 | |
| 2025-Q2 | |||||
| SELL | -2.8% | 37.3K | $17M | $450.27 | |
| 2025-Q1 | |||||
| SELL | -5.7% | 38.3K | $19M | $474.50 | |
| 2024-Q4 | |||||
| SELL | EXIT | — | — | $468.13 | |
| SELL | -24.2% | 40.6K | $16M | $468.13 | |
| 2024-Q3 | |||||
| BUY | NEW | 124.0K | $58M | $480.30 | |
| SELL | -1.4% | 53.6K | $25M | $480.30 | |
| 2024-Q2 | |||||
| SELL | -18.5% | 54.3K | $25M | $429.93 | |
| 2024-Q1 | |||||
| SELL | -0.1% | 66.7K | $28M | $420.74 | |
| 2023-Q4 | |||||
| SELL | -11.0% | 66.8K | $27M | $363.04 | |
| 2023-Q3 | |||||
| BUY | NEW | 75.0K | $26M | $349.53 | |
Insider Trading for Vertex Pharmaceuticals Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.